Richard J. Robbins
Papers
3
Total Citations
274
H-Index
3
About
Richard J. Robbins is a pioneering researcher in the field of functional proteomics and cancer biomarker discovery, with a particular focus on serum peptidomics as a diagnostic tool for malignant disease. His most influential work has centered on identifying novel molecular signatures in human serum that can distinguish cancer patients from healthy individuals, most notably in the context of metastatic thyroid carcinoma. His landmark 2006 study, which has garnered 178 citations, demonstrated that serum peptidome patterns could reliably differentiate metastatic thyroid cancer from cancer-free controls, importantly showing these signatures to be unbiased by gender or age — a critical validation for clinical applicability. Robbins further advanced the field by developing the Sequence-specific Exopeptidase Activity Test (SSEAT), a methodological innovation enabling real-time profiling of genuine enzymatic activities within complex biological matrices, accumulating 86 citations since its 2007 publication. His broader contributions to serum peptide profiling have helped establish mass spectrometry-based approaches as a credible platform for early cancer detection. Robbins' work collectively represents a meaningful step toward non-invasive, functionally grounded biomarker strategies in oncology diagnostics.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3